Meeting Highlights: 1. Elect chair; 2. Bylaws revision; 3. Report on HHSC decisions on acceptance of the DUR recommendations from the April 27, 2018, meeting; and 4. Public comment on drug classes and therapeutic and clinical drug reviews to be reviewed for the Medicaid PDL.